Anti-obesity and metabolic efficacy of the β3-adrenergic agonist, CL316243, in mice at thermoneutrality compared to 22°C

Obesity

Volumn 23, Issue 7, 2015, Pages 1450-1459

  Xiao, Cuiying ^a   Goldgof, Margalit ^a   Gavrilova, Oksana ^a   Reitman, Marc L ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; GLUCOSE; 1,3 DIOXOLANE DERIVATIVE; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIOBESITY AGENT; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; DISODIUM (R,R)-5-(2-((2-(3-CHLOROPHENYL)-2-HYDROXYETHYL)-AMINO)PROPYL)-1,3-BENZODIOXOLE-2,3-DICARBOXYLATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SELECTIVITY; ENERGY EXPENDITURE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; LIPID DIET; MALE; METABOLIC RATE; MOUSE; NONHUMAN; OBESITY; ROOM TEMPERATURE; TEMPERATURE DEPENDENCE; WHITE ADIPOSE TISSUE; ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DRUG EFFECTS; EATING; ENERGY METABOLISM; METABOLISM; PHYSIOLOGY; TEMPERATURE; THERMOGENESIS; WEIGHT REDUCTION;

MUS;

ADIPOSE TISSUE; ADRENERGIC AGONISTS; ADRENERGIC BETA-3 RECEPTOR AGONISTS; ANIMALS; ANTI-OBESITY AGENTS; BODY WEIGHT; DIOXOLES; EATING; ENERGY METABOLISM; MALE; MICE; MICE, INBRED C57BL; OBESITY; TEMPERATURE; THERMOGENESIS; WEIGHT LOSS;

EID: 84933182928     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21124     Document Type: Article

References (40)

1. Celi FS, Brychta RJ, Linderman JD, et al., Minimal changes in environmental temperature result in a significant increase in energy expenditure and changes in the hormonal homeostasis in healthy adults. Eur J Endocrinol 2010; 163: 863-872.
2. Wijers SL, Schrauwen P, van Baak MA, Saris WH, van Marken Lichtenbelt WD,. Beta-adrenergic receptor blockade does not inhibit cold-induced thermogenesis in humans: possible involvement of brown adipose tissue. J Clin Endocrinol Metab 2011; 96: E598-E605.
3. Cannon B, Nedergaard J,. Nonshivering thermogenesis and its adequate measurement in metabolic studies. J Exp Biol 2011; 214: 242-253.
4. Gordon CJ,. Thermal physiology of laboratory mice: defining thermoneutrality. J Thermal Biol 2012; 37: 654-685.
5. Abreu-Vieira G, Xiao C, Gavrilova O, Reitman ML., Integration of body temperature into the analysis of energy expenditure in the mouse. Mol Metab 2015; 4, (in press).
6. Whittle A, Relat-Pardo J, Vidal-Puig A,. Pharmacological strategies for targeting BAT thermogenesis. Trends Pharmacol Sci 2013; 34: 347-355.
7. Tseng YH, Cypess AM, Kahn CR,. Cellular bioenergetics as a target for obesity therapy. Nat Rev Drug Discov 2010; 9: 465-482.
8. Speakman JR, Keijer J,. Not so hot: optimal housing temperatures for mice to mimic the environment of humans. Mol Metab 2013; 2: 5-9.
9. Nedergaard J, Cannon B,. The browning of white adipose tissue: some burning issues. Cell Metab 2014; 20: 396-407.
10. Rippe C, Berger K, Boiers C, Ricquier D, Erlanson-Albertsson C,. Effect of high-fat diet, surrounding temperature, and enterostatin on uncoupling protein gene expression. Am J Physiol Endocrinol Metab 2000; 279: E293-E300.
11. Nikonova L, Koza RA, Mendoza T, Chao PM, Curley JP, Kozak LP,. Mesoderm-specific transcript is associated with fat mass expansion in response to a positive energy balance. FASEB J 2008; 22: 3925-3937.
12. Feldmann HM, Golozoubova V, Cannon B, Nedergaard J,. Ucp1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab 2009; 9: 203-209.
13. Lowell BB, Susulic VS, Hamann A, et al., Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 1993; 366: 740-742.
14. Susulic VS, Frederich RC, Lawitts J, et al., Targeted disruption of the beta 3-adrenergic receptor gene. J Biol Chem 1995; 270: 29483-29492.
15. Goldgof M, Xiao C, Chanturiya T, Jou W, Gavrilova O, Reitman ML,. The chemical uncoupler 2,4-dinitrophenol (DNP) protects against diet-induced obesity and improves energy homeostasis in mice at thermoneutrality. J Biol Chem 2014; 289: 19341-19350.
16. Arch JR,. beta(3)-adrenoceptor agonists: potential, pitfalls and progress. Eur J Pharmacol 2002; 440: 99-107.
17. Lowell BB, Flier JS,. Brown adipose tissue, beta 3-adrenergic receptors, and obesity. Ann Rev Med 1997; 48: 307-316.
18. Inokuma K, Okamatsu-Ogura Y, Omachi A, et al., Indispensable role of mitochondrial ucp1 for antiobesity effect of beta3-adrenergic stimulation. Am J Physiol Endocrinol Metab 2006; 290: E1014-E1021.
19. Gavrilova O, Marcus-Samuels B, Reitman ML,. Lack of responses to a beta3-adrenergic agonist in lipoatrophic A-ZIP/F-1 mice. Diabetes 2000; 49: 1910-1916.
20. Granneman JG, Burnazi M, Zhu Z, Schwamb LA,. White adipose tissue contributes to UCP1-independent thermogenesis. Am J Physiol Endocrinol Metab 2003; 285: E1230-E1236.
21. de Souza CJ, Burkey BF,. Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans. Curr Pharm Des 2001; 7: 1433-1449.
22. Weyer C, Gautier JF, Danforth E Jr., Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes-an update. Diabetes Metab 1999; 25: 11-21.
23. Bloom JD, Dutia MD, Johnson BD, et al., Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). a potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent. J Med Chem 1992; 35: 3081-3084.
24. Guerra C, Koza RA, Yamashita H, Walsh K, Kozak LP,. Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J Clin Invest 1998; 102: 412-420.
25. Nagy TR, Krzywanski D, Li J, Meleth S, Desmond R,. Effect of group vs. single housing on phenotypic variance in C57BL/6J mice. Obes Res 2002; 10: 412-415.
26. Yu S, Gavrilova O, Chen H, et al., Paternal versus maternal transmission of a stimulatory G-protein alpha subunit knockout produces opposite effects on energy metabolism. J Clin Invest 2000; 105: 615-623.
27. Ravussin Y, Gutman R, LeDuc CA, Leibel RL,. Estimating energy expenditure in mice using an energy balance technique. Int J Obes (Lond) 2013; 37: 399-403.
28. Mayer J, Marshall NB, Vitale JJ, Christensen JH, Mashayekhi MB, Stare FJ,. Exercise, food intake and body weight in normal rats and genetically obese adult mice. Am J Physiol 1954; 177: 544-548.
29. Kim H, Pennisi PA, Gavrilova O, et al., Effect of adipocyte beta3-adrenergic receptor activation on the type 2 diabetic MKR mice. Am J Physiol Endocrinol Metab 2006; 290: E1227-E1236.
30. Oana F, Takeda H, Matsuzawa A, Akahane S, Isaji M, Akahane M,. Adiponectin receptor 2 expression in liver and insulin resistance in db/db mice given a beta3-adrenoceptor agonist. Eur J Pharmacol 2005; 518: 71-76.
31. Liu X, Perusse F, Bukowiecki LJ,. Mechanisms of the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats. Am J Physiol 1998; 274: R1212-R1219.
32. Yoshida T, Sakane N, Wakabayashi Y, Umekawa T, Kondo M,. Anti-obesity effect of CL 316,243, a highly specific beta 3-adrenoceptor agonist, in mice with monosodium-l-glutamate-induced obesity. Eur J Endocrinol 1994; 131: 97-102.
33. Himms-Hagen J, Cui J, Danforth E Jr,., et al. Effect of CL-316,243, a thermogenic beta 3-agonist, on energy balance and brown and white adipose tissues in rats. Am J Physiol 1994; 266: R1371-R1382.
34. Ghorbani M, Himms-Hagen J,. Appearance of brown adipocytes in white adipose tissue during CL 316,243-induced reversal of obesity and diabetes in zucker fa/fa rats. Int J Obes Relat Metab Disord 1997; 21: 465-475.
35. Ravussin Y, Xiao C, Gavrilova O, Reitman ML,. Effect of intermittent cold exposure on brown fat activation, obesity, and energy homeostasis in mice. PLoS One 2014; 9: e85876.
36. Wang GX, Zhao XY, Meng ZX, et al., The brown fat-enriched secreted factor nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. Nat Med 2014; 20: 1436-1443.
37. Larsen TM, Toubro S, van Baak MA, et al., Effect of a 28-d treatment with L-796568, a novel beta(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men. Am J Clin Nutr 2002; 76: 780-788.
38. Cypess AM, Weiner LS, Roberts-Toler C, et al., Activation of human brown adipose tissue by a β3-adrenergic receptor agonist. Cell Metab 2015; 21: 33-38.
39. Masutani S, Cheng HJ, Morimoto A, et al., beta3-adrenergic receptor antagonist improves exercise performance in pacing-induced heart failure. Am J Physiol Heart Circ Physiol 2013; 305: H923-H930.
40. Stanford KI, Middelbeek RJ, Townsend KL, et al., Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J Clin Invest 2013; 123: 215-223.